Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Microba Life Sciences Ltd
MAPCurrent price
0.16 AUD
0 AUD (0.00%)
Last closed
0.15 AUD
Company
www.microba.com
ISIN
AU0000209868
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
Australian Securities Exchange
Capitalization
77 090 257 AUD
Yield for 12 month
-32.61 %
1Y
3Y
5Y
10Y
15Y
MAP
Microba Life Sciences Limited provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland. It operates through two segments, Testing Services and Supplements, and Research and Development. The company also develops pathology, therapeutics, and diagnostics services based on the human gut microbiome. In addition, it offers MetaPanel, a metagenomic test for pathogen detection; MetaXplore, a diagnostics under the brand Co-Biome and MetaXplore; non-diagnostic personal and research testing services; and data-driven therapeutics platform that develops therapies for ulcerative colitis, inflammatory bowel disease, and autoimmune diseases, as well as microbiome databank. Microba Life Sciences Limited was incorporated in 2017 and is based in Brisbane, Australia. Address: 324 Queen Street, Brisbane, QLD, Australia, 4000
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
0.57 AUDP/E ratio
–Dividend Yield
–Current Year
+12 241 773 AUD
Last Year
+5 488 154 AUD
Current Quarter
+8 927 847 AUD
Last Quarter
+3 313 927 AUD
Current Year
+5 979 535 AUD
Last Year
-6 857 927 AUD
Current Quarter
-4 228 005 AUD
Last Quarter
-4 461 895 AUD
Key Figures MAP
1 year
3 years
5 years
10 years
EBITDA
-24 918 847 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-30.76 %
PEG Ratio
–
Return On Equity TTM
-49.98 %
Wall Street Target Price
0.57 AUD
Revenue TTM
12 241 773 AUD
Book Value
0.093 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
169.8 %
Dividend Yield
–
Gross Profit TTM
2 711 873 AUD
Earnings per share
-0.051 AUD
Diluted Eps TTM
-0.051 AUD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-164.92 %
Dividend Analytics MAP
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History MAP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation MAP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
4.7003
Price Sales TTM
6.1862
Enterprise Value EBITDA
-7.9984
Price Book MRQ
1.8472
Financials MAP
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators MAP
For 52 weeks
0.15 AUD
0.23 AUD
50 Day MA
0.18 AUD
Shares Short Prior Month
–
200 Day MA
0.18 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart